These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 11835393

  • 1. Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer.
    Ahmed N, Pansino F, Baker M, Rice G, Quinn M.
    J Cell Biochem; 2002; 84(4):675-86. PubMed ID: 11835393
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade.
    Ahmed N, Pansino F, Clyde R, Murthi P, Quinn MA, Rice GE, Agrez MV, Mok S, Baker MS.
    Carcinogenesis; 2002 Feb; 23(2):237-44. PubMed ID: 11872628
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma.
    Ahmed N, Riley C, Oliva K, Rice G, Quinn M.
    Br J Cancer; 2005 Apr 25; 92(8):1475-85. PubMed ID: 15798771
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.
    Ahmed N, Oliva K, Wang Y, Quinn M, Rice G.
    Br J Cancer; 2003 Jul 21; 89(2):374-84. PubMed ID: 12865932
    [Abstract] [Full Text] [Related]

  • 7. Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer.
    Xue B, Wu W, Huang K, Xie T, Xu X, Zhang H, Qi C, Ge J, Yu Y.
    Mol Cell Biochem; 2013 Aug 21; 380(1-2):177-84. PubMed ID: 23615713
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor-alpha-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: molecular basis linking ovulation and cancer risk.
    Yang WL, Godwin AK, Xu XX.
    Cancer Res; 2004 Feb 15; 64(4):1534-40. PubMed ID: 14973065
    [Abstract] [Full Text] [Related]

  • 9. U0126, a mitogen-activated protein kinase kinase inhibitor, inhibits the invasion of human A375 melanoma cells.
    Ge X, Fu YM, Meadows GG.
    Cancer Lett; 2002 May 28; 179(2):133-40. PubMed ID: 11888667
    [Abstract] [Full Text] [Related]

  • 10. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
    Nishikawa A, Iwasaki M, Akutagawa N, Manase K, Yamashita S, Endo T, Kudo R.
    Gynecol Oncol; 2000 Nov 28; 79(2):256-63. PubMed ID: 11063654
    [Abstract] [Full Text] [Related]

  • 11. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma.
    Moser TL, Young TN, Rodriguez GC, Pizzo SV, Bast RC, Stack MS.
    Int J Cancer; 1994 Feb 15; 56(4):552-9. PubMed ID: 8112891
    [Abstract] [Full Text] [Related]

  • 12. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H, Bulbule A, Kundu GC.
    J Biol Chem; 2004 Sep 10; 279(37):38921-35. PubMed ID: 15247285
    [Abstract] [Full Text] [Related]

  • 13. Basic calcium phosphate crystal induction of collagenase 1 and stromelysin expression is dependent on a p42/44 mitogen-activated protein kinase signal transduction pathway.
    Brogley MA, Cruz M, Cheung HS.
    J Cell Physiol; 1999 Aug 10; 180(2):215-24. PubMed ID: 10395291
    [Abstract] [Full Text] [Related]

  • 14. Nuclear factor inducing kinase: a key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H, Bulbule A, Kundu GC.
    Glycoconj J; 2006 May 10; 23(3-4):221-32. PubMed ID: 16691505
    [Abstract] [Full Text] [Related]

  • 15. MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription.
    Benasciutti E, Pagès G, Kenzior O, Folk W, Blasi F, Crippa MP.
    Blood; 2004 Jul 01; 104(1):256-62. PubMed ID: 15031204
    [Abstract] [Full Text] [Related]

  • 16. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z, Guo H, Wai PY, Gao C, Kuo PC.
    Carcinogenesis; 2006 Jun 01; 27(6):1134-45. PubMed ID: 16474180
    [Abstract] [Full Text] [Related]

  • 17. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
    Schmalfeldt B, Prechtel D, Härting K, Späthe K, Rutke S, Konik E, Fridman R, Berger U, Schmitt M, Kuhn W, Lengyel E.
    Clin Cancer Res; 2001 Aug 01; 7(8):2396-404. PubMed ID: 11489818
    [Abstract] [Full Text] [Related]

  • 18. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity.
    Huang S, New L, Pan Z, Han J, Nemerow GR.
    J Biol Chem; 2000 Apr 21; 275(16):12266-72. PubMed ID: 10766865
    [Abstract] [Full Text] [Related]

  • 19. Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells.
    Han Q, Leng J, Bian D, Mahanivong C, Carpenter KA, Pan ZK, Han J, Huang S.
    J Biol Chem; 2002 Dec 13; 277(50):48379-85. PubMed ID: 12377770
    [Abstract] [Full Text] [Related]

  • 20. Proteomic identification of lynchpin urokinase plasminogen activator receptor protein interactions associated with epithelial cancer malignancy.
    Saldanha RG, Molloy MP, Bdeir K, Cines DB, Song X, Uitto PM, Weinreb PH, Violette SM, Baker MS.
    J Proteome Res; 2007 Mar 13; 6(3):1016-28. PubMed ID: 17330942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.